NIPH's website uses cookies. Read more about our use of cookies in our privacy policy.
You will only receive an alert if new information was published since you received one.
The email address you register will only be used to send you these alerts. You can cancel your alerts and delete your email address at any time by following the link in the alerts you receive. Read more about the privacy policy for fhi.no
Fact sheets, statistics and advice about tuberculosis.
Fact sheet
Every year in Norway, 350-400 cases of tuberculosis are diagnosed. The incidence has increased in recent years. There are few new cases in Norway.
Updated 07.11.2016
Article
List of countries with a high occurrence of tuberculosis. People from these countries are required to undergo tests for tuberculosis.
Updated 24.11.2020
Specific groups in the population are at higher risk of TB infection and must undergo screening.
Updated 13.08.2019
Children in defined risk groups are offered the vaccine at the age of six weeks.
Updated 24.01.2020
Form
Obligatory for all asylum seekers and refugees, and for immigrants to Norway born in a country with high incidence of TB.
Published 08.04.2019
Information note
This information note gives simple and concise information about tuberculosis.
Published 08.11.2016
Information in several languages for people who will be routinely checked for tuberculosis upon arrival in Norway.
Each information note explains what it means to test positive, if it is dangerous or not, if the patient is infectious and what to be aware of.
Brochure
This brochure gives information about vaccination against tuberculosis and is intended for parents who come from countries with a high incidence of the disease.
Published 17.06.2016
It is important to treat tuberculosis. This treatment is free of charge in Norway. The information letter about tuberculosis is currently available in 15 different languages.
Updated 13.02.2018
Project
A rapid serological screening method for detecting tuberculosis disease and monitoring the efficacy of new vaccines.
Published 17.01.2019
Tuberculosis (TB) remains a major preventable cause of morbidity. Bacillus Calmette Guerin (BCG) vaccines are widely used to protect against TB. Their efficacy shortly after vaccination has been demon
Updated 25.02.2021
SeroSelectTB is a multinational project coordinated by the Norwegian Institute of Public Health.
Updated 09.03.2021
The objective of this study is to explore the prevalence of risk factors among persons screened for LTBI or who have been notified to MSIS (TB register), and assess the impact of these factors in a No...
This population-based prospective cohort study includes house-to-house active case finding (three visits) in Dale District in Sidama Zone (53 000 households).
Updated 11.12.2018
